Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Poster presentations

J. C. Contassot and co-workers, "Epidemiological Study of Cancer Morbidity Among Workers Exposed to Hydrazine," poster presented at the XXII International Congress on Occupational Health, in Sydney, AustraUa, Sept.—Oct., 1987. [Pg.295]

S. B. Damle and J. A. Krogh, posters presented at The Third Chemical Congress of North A.merica, Toronto, Canada, June 5—10,1988 Biol Chem. Abstr. 21, 22, (1988). [Pg.46]

Kast, E., Pathmanbhan, N., Wong, J., O Connor, B., and Klein, M. (1996). Poster presented at Protein Society 1996, Preparative Isolation of Immunoglobulin Heavy and Light Chains by Size-Exclusion Chromatogtaphy . [Pg.157]

J. Breinholt, A. Varming, Poster presented at the 11 International Symposium on Chiral Discrimination, Chicago, July 1999. [Pg.22]

Cabrera, K., Lubda, D., Bohne, S., Schafer, M., Poster presentation 3" International Symposium on Chiral Discrimination, Tubingen, 1992... [Pg.202]

Nagamatsu S. and Makino S., poster presented during the International Symposium on Chiral Discrimination, Nagoya, 1997. [Pg.284]

The students discuss these ideas and propose experiments to verily or falsify one of the presented theories. From a methodical point of view, several approaches from discussions, poster presentations up to actual role-plays are possible. The students have the possibility to choose one of the scientists as an advocate for their preconceptions. Using this technique, it will be easier for the students to express and defend their conception in classroom. [Pg.238]

Bryan RF (1978) Poster Presentation at the 7th International Congress on Liquid Crystals, Bordeaux, France... [Pg.193]

Caekelbergh K et al (2007) Cost of care for HIV/AIDS in Belgium according to disease stage. Poster presented at the 11th European AIDS Conference/EACS, 24-27 October 2007, Code P19,5/01... [Pg.371]

Grimes PE, Callender VD (2003) Tazarotene cream 0.1% in the treatment of facial post-inflammatory hyperpigmentation associated with acne vulgaris a two-center, double-blind, randomized, vehicle-controlled study. Poster presentation at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, CA, March 21-26,2003... [Pg.182]

Almond S, O Donnell O, McKendrick J (1999). A cost analysis of olanzapine compared with haloperidol and risperidone in the treatment of schizophrenia in the UK. Poster presented at the 12th Congress of the European College of Neuropsychopharmacology, London, 21-25 September 1999. [Pg.38]

Byrom WD, Kilpatrick AT, Garratt CJ (1998a). The perceived costs of newer antipsychotics may be unfounded — Predictions of a decision-free model. Poster presented at 11th ECNP Congress, Paris, 31 October—4 November 1998. [Pg.38]

Poster presented at the 12th Congress of the European College of Neuropsychopharmacology, London, 21-25 September 1999. [Pg.39]

Edgell ET, Hamilton SH, Revicki DA, et al (1998). Costs of olanzapine treatment compared with haloperidol for schizophrenia results from a randomized clinical trial. Poster presented at the 21st CINP Congress, Glasgow, July 1998. [Pg.39]

Grainger DL, Hamilton SH, Genduso LA, et al (1998a). Medical resource use and work and social outcomes for olanzapine compared with haloperidol in the treatment of schizophrenia and other psychotic disorders. Poster presented at the 21st Congress of the CINP, Gla ow, July 1998. [Pg.39]

Health economic audit of long-term treatment with Seroquef for patients with chronic schizophrenia. Poster presented at the European College of Neuropharmacology, 1998. [Pg.40]

Spannheimer A, Clouth J, Gregor KJ (1999). Pharmacoeconomic evaluation of the rrearmenr of schizophrenia in Germany a comparison of olanzapine, risperidone and haloperidol using a clinical decision model. Poster presented at the ISPOR Second Annual European Meeting, Edinburgh, November 1999. [Pg.42]

Changes in perceived physical and mental health status of a schizophrenia patient population following initiation of a conventional or an atypical antipsychotic medication. Poster presented at the American Psychiatric Association Annual Meeting, Toronto, June 1998. [Pg.42]

Weiss MA, McCollum M (1998). Cost impact of using olanzapine at a Veterans Affairs Medical Center. Poster presentation at the Third Annual Meeting of ISPOR, Philadelphia, May 1998. Abstract published in Value Health 1, 25. [Pg.42]

H. Diserens and M. Henzehn, Poster presented at the 1 st European Pesticide Residue Workshop, Alkmaar, The Netherlands (1996). [Pg.1098]

Belshaw NS, Pike AWG, Henderson GM (2002) U-series dating of archaeological bone material by laser ablation mnltiple-ion-counter ICP-MS. Poster presented at Golschmidt 2002 conference. 18th-25th Angnst 2002, Davos, Swtizerland... [Pg.626]

Ulfelder, K., Anderson, K., and Schwartz, H. E., Analysis of PCR products and DNA restriction fragments to detect AIDS (HIV-1) virus in blood, poster presentation, HPCE 91, San Diego, CA, 1991. [Pg.421]

Adis Conference Insight. Conference Insight [79] provides coverage of 45 general and specialty medical meetings each year with reviews of conference themes, executive overviews, and reports on oral and poster presentations. This resource is commercially available in several formats. [Pg.776]

Aldous DJ, Diana GD, Treasurywala AM, Jaeger EP, Pevear DC. Progress in the development of an antirhinovirus model based on small molecule conformations, Poster presentation 28 presented at the American Chemical Society Meeting, San Diego, CA, 1994. [Pg.311]


See other pages where Poster presentations is mentioned: [Pg.31]    [Pg.89]    [Pg.181]    [Pg.261]    [Pg.313]    [Pg.355]    [Pg.434]    [Pg.86]    [Pg.302]    [Pg.40]    [Pg.40]    [Pg.42]    [Pg.270]    [Pg.271]    [Pg.63]    [Pg.108]   


SEARCH



Poster

Poster presentation Posters, designing

Poster presentation color

Poster presentation examples

Poster presentations components

© 2024 chempedia.info